BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7025343)

  • 1. Urokinase therapy: dose reduction by administration in plastic material.
    Zimmermann R; Schöffel G; Harenberg J
    Thromb Haemost; 1981 Jun; 45(3):296. PubMed ID: 7025343
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urokinase dosage in deep venous thromboses].
    Theiss W; Kriessmann A; Wirtzfeld A
    Dtsch Med Wochenschr; 1980 Jun; 105(24):873. PubMed ID: 6998691
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of potentiation and rapid action in models of venous thrombosis in dogs upon combined administration of the plasminogen tissue activator and urokinase modified by fibrinogen].
    Maksimenko AV; Tishchenko EG; Petrova ML; Golubykh VL
    Biull Eksp Biol Med; 1996 Jan; 121(1):48-51. PubMed ID: 8680005
    [No Abstract]   [Full Text] [Related]  

  • 4. Modifications in coagulation parameters induced by treatment associating urokinase (2000 u CTA/kg/h) with heparin.
    Juhan I; Calas MF; Buonocore M; Mathieu P; Isnard G; Cazenave B; Serradimigni A
    Thromb Haemost; 1979 Oct; 42(3):945-54. PubMed ID: 315625
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on thrombolytic therapy for venous thrombosis in the extremities--dynamics of plasmin inhibitor and FDP following administration of urokinase (author's transl)].
    Takeuchi S; Shiba T
    Nihon Geka Hokan; 1979 May; 48(3):354-61. PubMed ID: 157109
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of thrombolytic agents.
    Wolf P
    N Engl J Med; 1980 Apr; 302(14):812. PubMed ID: 6444451
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dosage and control of thrombolysis therapy using urokinase].
    Zimmermann R; Mörl H
    Dtsch Med Wochenschr; 1980 Mar; 105(12):419-20. PubMed ID: 6988188
    [No Abstract]   [Full Text] [Related]  

  • 8. Some aspects of the dose-response relation in urokinase administration.
    Matsuo O; Rokushima Y
    Thromb Res; 1976 May; 8(2 suppl):97-106. PubMed ID: 936100
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological changes during the local administration of small doses of urokinase].
    Michaud A; Aiach M; Fiessinger JN; Vayssairat M; Juillet Y
    Nouv Presse Med; 1978 Oct; 7(35):3151. PubMed ID: 152910
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dosage of urokinase in venous thrombosis of the lower extremities].
    Zimmermann R; Harenberg J
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1228. PubMed ID: 7000484
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with urokinase in chronic arterial occlusive disease and long-standing phlebothrombosis].
    Trübestein G; Brecht T; Brecht G; Etzel F
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1948-50. PubMed ID: 1030145
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental and clinical studies of cyclophosphamide and urokinase administration in the field of gyneco-obstetrics].
    Matsumoto M
    Igaku Kenkyu; 1975 Jul; 45(3):147-59. PubMed ID: 1239904
    [No Abstract]   [Full Text] [Related]  

  • 13. Urokinase therapy in the early stage of acute myocardial infarction.
    Ohmae K; Satow Y
    Hiroshima J Med Sci; 1981 Jun; 30(2):109-14. PubMed ID: 7028683
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of oral urokinase and its clinical application.
    Abe T; Kazama M; Naito I; Kinoshita T; Sasaki K
    New Istanbul Contrib Clin Sci; 1982; 13(3):161-70. PubMed ID: 6760114
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasminogen and moderate doses of urokinase in the treatment of acute pulmonary embolism.
    Griguer P; Charbonnier B; Latour F; Fauchier JP; Brochier M
    Angiology; 1979 Jan; 30(1):1-12. PubMed ID: 426316
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Thrombolytic therapy of deep venous thromboses with urokinase.
    Theiss W; Kriessmann A; Wirtzfeld A
    Thromb Diath Haemorrh; 1975 Nov; 34(2):568-9. PubMed ID: 1198453
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience with thrombolytic therapy using urokinase].
    de Donato A; Piccolo GR; de Luca G
    Minerva Cardioangiol; 1984; 32(7-8):505-14. PubMed ID: 6493533
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dosage and control of thrombolysis therapy using urokinase].
    Tilsner V
    Dtsch Med Wochenschr; 1980 Apr; 105(17):618. PubMed ID: 6989581
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inefficiency of high doses of urokinase in a massive pulmonary embolism. Possible role of an oral contraceptive].
    Grand A; Drouin B; Ferry M; Heulin T; Murger JF
    Nouv Presse Med; 1978 Jul 1-8; 7(27):2391. PubMed ID: 673811
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dosage and control of thrombolysis therapy using urokinase].
    Trübestein G
    Dtsch Med Wochenschr; 1980 May; 105(20):736-7. PubMed ID: 6989584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.